Connors Investor Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,070
Closed -$208K 148
2018
Q4
$208K Sell
1,070
-57
-5% -$11.1K 0.03% 127
2018
Q3
$234K Buy
1,127
+22
+2% +$4.34K 0.03% 131
2018
Q2
$204K Buy
+1,105
New +$195K 0.03% 136
2017
Q4
Sell
-1,105
Closed -$206K 148
2017
Q3
$206K Buy
+1,105
New +$196K 0.03% 151
2016
Q2
Sell
-1,140
Closed -$171K 152
2016
Q1
$171K Buy
+1,140
New +$169K 0.03% 149
2015
Q1
Sell
-1,500
Closed -$239K 167
2014
Q4
$239K Hold
1,500
0.05% 123
2014
Q3
$211K Buy
+1,500
New +$196K 0.05% 130

Other funds holding AMGN

Connors Investor Services's AMGN Position: Q1 2019 in Review

Connors Investor Services sold out of Amgen (AMGN) in Q1 2019, closing a stake of 1,070 shares — an estimated $208K sold.

Connors Investor Services first reported a position in AMGN in Q3 2014 and held it in 7 quarters. The position peaked at $239K in Q4 2014. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Connors Investor Services reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Connors Investor Services sold 1,070 Amgen shares in Q1 2019, an estimated $208K.
  • Connors Investor Services first reported a position in Amgen in Q3 2014 and held it in 7 quarters.
  • Connors Investor Services's Amgen position peaked at $239K in Q4 2014.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Connors Investor Services's 13F filing for Q1 2019, filed 10 May 2019.